Fytexia
13
1
2
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.4% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
GreenArt: Nutrikinetics and Bioavailability Studies
Role: lead
Modulation of Appetite Signaling Through Enterohormone Stimulation by DNF-10
Role: lead
OXXYNEA® GS: Study for Glycaemia Management
Role: lead
Oral Bioavailability of the Phenolic Compounds in a Melissa Supplement
Role: lead
Poplar-type Propolis Dry Extract ESIT12 : Immunomodulation Efficacy Study
Role: lead
Poplar-type Propolis Dry Extract ESIT12 : Nutrikinetic and Bioavailability Studies
Role: lead
Evaluation of Mangoselect® in Improvement of Exercise/Activity-induced Knee Joint Discomfort in Subjects Suffering From Osteoarthritis Grade I or II
Role: lead
Evaluation of OxxyneaGS in Acute Glycemic Regulation on Light Hyperglycemic Subjects
Role: lead
Mangoselect®: Characterization, Pharmacokinetics and Bioavailability of Xanthone Metabolites
Role: lead
Evaluation of Sinetrol® Xpur in Fat Mass Reduction on Overweight and Obese Subjects
Role: lead
Bioavailability, Pharmacokinetic and Mechanistic Study of Sinetrol® Xpur, a Polyphenol-rich Ingredient
Role: lead
Evaluation of Bioavailability of Phenolic Compounds From Oxxynea®
Role: lead
Evaluation of Fiit-ns® in Health-related Quality of Life Improvement in Overweight and Obese Subjects
Role: lead
All 13 trials loaded